Neutralization of CD73 synergized with anti-HER2 monoclonal therapy, eliminated HER2+ tumor growth in syngeneic models as well as reduced pulmonary metastasis (Turcotte et al., 2017). This evidence concerns the gene NT5E and neoplasm.